RLS Global
0,53 SEK +2,71 %Vær den første som følger denne virksomhed
RLS Global is a Swedish biochemistry company. The company develops and sells biochemical products and methods for the treatment of existing diseases. The company's products attack damaged tissue and leave healthy intact. The company conducts research and development in tissue-based technology. The company is headquartered in Gothenburg.
Omsætning
1,2 mio.
EBIT %
-2.030,83 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
RLS
Daglig lav / høj pris
0,46 / 0,542
SEK
Markedsværdi
42,33 mio. SEK
Aktieomsætning
2,23 t SEK
Volumen
4,7 t
Finanskalender
Delårsrapport
23.11.2023
Årsrapport
29.02.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| RLS Global Intressenter AB | 24,8 % | 24,8 % |
| BK Julius Baer & Co Sweden | 15,2 % | 15,2 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper